Mizuho Securities raised its price target on Quest Diagnostics, while Jefferies Financial Group issued a buy rating and price target for the company.
1 report, 1 independent
Updated Aug 14
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Mizuho Securities raised its price target on Quest Diagnostics, while Jefferies Financial Group issued a buy rating and price target for the company.